|Bid||0.00 x 800|
|Ask||0.00 x 1100|
|Day's Range||60.00 - 60.45|
|52 Week Range||53.77 - 63.76|
|PE Ratio (TTM)||N/A|
|Beta (3Y Monthly)||0.87|
|Expense Ratio (net)||0.47%|
With the healthcare sector recently outperforming technology, investors have been embracing healthcare exchange traded funds. The Health Care Select Sector SPDR (XLV) is the largest healthcare ETF by assets. XLV allocates about two-thirds of its combined weight to pharmaceuticals and biotechnology stocks.
The healthcare sector is the second-largest sector exposure in the S&P 500. This prominence is reflected in the world of exchange-traded funds (ETFs), where there are dozens of healthcare ETFs.
Merck’s (MRK) immunology products include Simponi and Remicade. Its cardiovascular products include Zetia, Vytorin, Adempas, and Atozet.
The non-farm payrolls for March rose by 103,000, which was below the consensus expectation of 193,000 jobs being added and way below the February number of 326,000 jobs. The unemployment rate for March remained unchanged at 4.1%.
BlackRock announces that the iShares Board of Trustees and Board of Directors have authorized a share split for iShares Global 100 ETF , iShares Global Healthcare ETF , iShares Global Consumer Staples ETF and iShares MSCI EM ESG Optimized ETF .